Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|MAGE-A3 vaccine||GL-0817||MAGE-A3 vaccine is a large peptide vaccine containing a membrane translocation sequence that is delivered into the endoplasmic reticulum where it facilitates the formation of MHC class 1 complexes (PMID: 24520093).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|
|NCT02873819||Phase II||MAGE-A3 vaccine Cyclophosphamide + Poly ICLC + Sargramostim||Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity||Active, not recruiting|